Related Experiment Video
Updated: Jan 10, 2026

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
Published on: June 28, 2019
Re-evaluating omega-3 (EPA/DHA) in cancer prevention and management.
Alessio Molfino1,2, Maurizio Muscaritoli2, Federica Tambaro2
1Department of Interdisciplinary Studies on WellBeing, Health and Environmental Sustainability (BeSSA).
Omega-3 fatty acids show promise in cancer prevention and managing cachexia. While eicosapentaenoic acid (EPA) is linked to reduced colorectal cancer risk, benefits for other outcomes require further research.
Area of Science:
- Oncology
- Nutritional Science
- Molecular Biology
Background:
- Omega-3 polyunsaturated fatty acids (PUFAs) are essential fats with potential roles in cancer. Emerging evidence highlights their impact on various aspects of cancer care.
- Understanding the specific roles of different omega-3s, like EPA and DHA, is crucial for targeted applications.
Purpose of the Study:
- To review recent evidence on omega-3 PUFAs in oncology.
- Focus areas include cancer prevention, cachexia, treatment toxicities, and therapeutic response.
Main Methods:
- Systematic review of recent epidemiological, biomarker, and clinical studies.
- Analysis of data on omega-3 fatty acids, cancer risk, cachexia management, and treatment side effects.
Main Results:
- Consistent inverse association between EPA and colorectal cancer risk; DHA evidence is less clear.
- Omega-3 rich diets (Mediterranean, MIND) are linked to reduced cancer risk.
- Supplementation shows benefits in cancer cachexia (body weight, inflammation, quality of life) but variable effects on lean mass.
- Promising reduction in oral mucositis; inconclusive results for neuropathy and chemosensitization due to study heterogeneity.
Conclusions:
- Omega-3 fatty acids have demonstrable biological and clinical effects in oncology.
- Benefits are context-dependent, requiring further investigation.
- Future research should standardize interventions, stratify patients, and integrate omega-3s into immunonutrition for precision oncology.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

